AKT2 Oncogene and Phosphoinositide 3-Kinase in Human Breast Cancer

doi 10.21236/ada430371
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?

Clinical Cancer Research
Cancer ResearchOncology
2009English

The Role of AKT2 in Human Breast Cancer

2004English

Phosphoinositide 3-Kinase Inhibitors in Lymphoma

Current Opinion in Oncology
Cancer ResearchOncology
2014English

Phosphoinositide 3-Kinase-Δ (PI3Kδ); Phosphoinositide 3-Kinase Catalytic Subunit Δ-Polypeptide (PI3KCD; P110δ)

Science-Business eXchange
2014English

EN2 Is a Candidate Oncogene in Human Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Phosphoinositide 3-Kinase-Γ (PI3Kγ)

Science-Business eXchange
2011English

Phosphoinositide 3-Kinase-Β (PI3Kβ); PI3Kδ

Science-Business eXchange
2011English

Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy